EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double‐blind, placebo‐controlled pilot study

Xiu Cai Fang iD, Zhi Hui Lin iD, Yong Dong Wu, De An Tian, Shi Liu, Dong Sheng Wu, Han Lin, Fan Dong Meng, Mei Liu, Fan Du, Hui Jun Shu, Zhi Feng Wang und 4 weitere

Journal of Digestive Diseases · 2023

DOI: 10.1111/1751-2980.13237 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Digestive Diseases, 2023. Verfasst von Xiu Cai Fang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, Ch…. Hauptthemen laut MEDLINE: Dyspepsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This pilot study aimed to evaluate the efficacy and safety of domperidone for the treatment of Chinese patients with functional dyspepsia (FD) who were diagnosed according to the Rome IV criteria and to identify the FD subtypes that potentially responded better to domperidone.

Methods

This multicenter prospective study was conducted in China from August 2018 to July 2020, consisting of a 1‐week screening phase and a 2‐week double‐blind treatment phase. Participants were randomized to receive domperidone 10 mg or matching placebo tablets thrice daily for 14 days. The primary end‐point was the overall treatment effect (OTE) response rate after 2‐week therapy.

Results

Altogether 160 patients were included, with 80 patients in each group. The OTE response rate after 2‐week therapy was significantly higher for domperidone compared with placebo (60.7% vs 46.0%; relative risk [RR] 1.318, 95% confidence interval [CI] 0.972–1.787). Moreover, the OTE response rate after 2‐week domperidone or placebo treatment was 60.3% versus 54.9% for postprandial distress syndrome (PDS) (RR 1.098, 95% CI 0.750–1.607) and 60.6% versus 35.2% for overlapping PDS–epigastric pain syndrome (EPS) (RR 1.722, 95% CI 0.995–2.980). Adverse events were reported by seven patients in the domperidone group and 12 patients in the placebo group. None of the adverse events in the domperidone group were serious.

Conclusion

Domperidone showed a positive pattern regarding OTE response rates after 2‐week therapy compared to placebo in patients with FD, as well as in subtypes of PDS and overlapping PDS–EPS. No new safety issue was observed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DyspepsiaAdultHumansDomperidonePilot ProjectsProspective StudiesDouble-Blind MethodTreatment Outcome

Stichwörter der Autor:innen

Nepean dyspepsia indexdomperidonefunctional dyspepsiapostprandial distress syndrome

Substanzen

Domperidone

Autor:innen und Institutionen

  • Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Department of Gastroenterology, Fujian Provincial Hospital, Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, China.
  • Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
  • Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
  • Janssen China R&D, Shanghai, China.

ORCID-Profile: Xiu Cai Fang, Zhi Hui Lin

Zitieren

APA

Fang, X. C., Lin, Z. H., Wu, Y. D., Tian, A., Liu, S., Wu, D. S., Lin, H., Meng, F. D., Liu, M., Du, F., Shu, H. J., Wang, Z. F., Zhuo, J. M., Wang, P., Li, M. Y., & Xu, J. (2023). Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double‐blind, placebo‐controlled pilot study. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13237

Vancouver

Fang XC, Lin ZH, Wu YD, Tian A, Liu S, Wu DS, et al. Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double‐blind, placebo‐controlled pilot study. Journal of Digestive Diseases. 2023. doi:10.1111/1751-2980.13237

BibTeX
@article{Fang2023,
  author = {Fang, Xiu Cai and Lin, Zhi Hui and Wu, Yong Dong and Tian, De An and Liu, Shi and Wu, Dong Sheng and Lin, Han and Meng, Fan Dong and Liu, Mei and Du, Fan and Shu, Hui Jun and Wang, Zhi Feng and Zhuo, Jian Min and Wang, Ping and Li, Meng Yu and Xu, Jian},
  title = {Treatment of functional dyspepsia in Chinese adult patients with domperidone: A multicenter, randomized, double‐blind, placebo‐controlled pilot study},
  journal = {Journal of Digestive Diseases},
  year = {2023},
  doi = {10.1111/1751-2980.13237}
}
Kostenlos starten →